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INTRODUCTION 
Oral Delivery Geriatric patient
- Physiological and 
neurological changing
- Difficulty in swallowing 
- Hand tremors 
Inconvenient to use 
conventional tablets
Poor patient complianceOrally Disintegrating Tablets
INTRODUCTION 






widely used in hypertension 
therapy 
Orally Disintegrating 
Tablets of Atenolol 
Superdisintegran
Rapid disintegration without gel 
formation on the surface of 
tabletsCrospovidone







Atenolol 25 25 25
Crospovidone - 30 60
Aspartam 9 9 9
Mg Stearat 4,5 4,5 4,5
Aerosil 1,5 1,5 1,5
Talk 3 3 3
Mint Flavour 3 3 3
Manitol DC 50,8 44,8 38,8
Avicel PH 102® 203,2 179,2 155,2
Bobot total per tablet 300 300 300
CPV 0%
CONTROL 
CPV 10% CPV 20%
METHOD
Mixing of the drug and excipients
Pre compression evaluation
(flowability, compressibility, Hausner ratio, moisture content) 
Compression
Post compression evaluation
(% drug content, hardness, wetting time, water uptake ratio, in 
vitro dispersion time, friability, dissolution) 





RESULT AND DISCUSSION 
PRE COMPRESSION EVALUATION
Parameter Formula Specification
Formula 1 Formula 2 Formula 3
Flowability (g/detik) 9,31 ± 0,16 6.88 ± 0,32 7,37 ± 0,18 4-10 g/detik
Angle of repose (°) 32,15 ± 0,00 32,15 ± 0,00 35,54 ± 0,00 25°-35°
Compressibility index (%) 23,69 ± 0,50 19,67 ± 0,00 25,73 ± 0,00 <10% -20%
Hausner ratio 1,32 ± 0,006 1,24 ± 0,011 1,34 ± 0,006 < 1,25
Moisture content (%) 4,80 ± 0,24 5,52 ± 0,18 5,54 ± 0,07 3-5%






RESULT AND DISCUSSION 
POST COMPRESSION EVALUATION
Parameter Formula Spesification
Formula 1 Formula 2 Formula 3
Organoleptic Round white tablet, 
sweet and mint odor
Round white tablet, 
sweet and mint odor
Round white tablet, 
sweet and mint odor
Round white 
tablet, sweet and 
mint odor
Drug content (%) 93,99 ± 0,13 100,21 ± 2,45 98,81 ± 2,31 90,0-110,0%
Hardness (kP) 2,85 ± 0,24 2,40 ± 0,52 2,75 ± 0,42 2-4 kP
Wetting time (seconds) 7,00 ± 1,00 4,00 ± 0,00 7,00 ± 0,00
Water absorption ratio (%) 126,78` ±1,89 57,23 ± 1,18 60,47 ± 0,62
Disintegration time
(seconds)
4,00 ± 0,00 15,48 ± 1,16 19,85 ± 0,95 < 30 second
In vitro dispersion time
(second)
15,00 ± 0,00 8,00 ± 1,00 13,00 ± 1,00
Friabilility (%) 0,20 ± 0,09 0,61 ± 0,19 2,26 ± 0,66 < 1%
% Q (dissolution) 53,85 86,17 87,05 % Q > 85% in 30 
minutes





















Kanig and Rudnic , 1984; Hahm and Augsburger, 2008.
Crospovidone 
Crospovidone not swell as much on contact with water









There was a significant difference of dissolution 
efficiency (ED) between formula 1, formula 2, and 
formula 3 
Formula 2 (10% CPV) showed the highest dissolution
efficiency. Dissolution efficiency of formula 2 fold
approximately 2,2 compare to formula 1 (control)
CONCLUSION
- The difference of crospovidone concentration in atenolol orally 
disintegrating tablet affect the physicochemical characteristics 
of  orally disintegrating tablet.
- The optimum formula was formula 2 (10% crospovidone)
